TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biotage AB
Closing information (x1000 NOK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
2,120,348
|
1,886,265
|
1,481,299 |
| Financial expenses |
69,097
|
41,534
|
13,243 |
| Earnings before taxes |
338,266
|
306,949
|
329,178 |
| EBITDA |
585,777
|
469,034
|
405,797 |
| Total assets |
5,263,743
|
4,995,259
|
2,212,490 |
| Current assets |
1,400,502
|
1,465,857
|
975,236 |
| Current liabilities |
596,090
|
710,135
|
391,608 |
| Equity capital |
4,241,727
|
3,704,657
|
1,548,459 |
| - share capital |
116,537
|
113,460
|
87,970 |
| Employees (average) |
673
|
674
|
517 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
80.6%
|
74.2%
|
70.0% |
| Turnover per employee |
3,151
|
2,799
|
2,865 |
| Profit as a percentage of turnover |
16.0%
|
16.3%
|
22.2% |
| Return on assets (ROA) |
7.7%
|
7.0%
|
15.5% |
| Current ratio |
234.9%
|
206.4%
|
249.0% |
| Return on equity (ROE) |
8.0%
|
8.3%
|
21.3% |
| Change turnover |
200,072
|
299,857
|
315,935 |
| Change turnover % |
10%
|
19%
|
27% |
| Chg. No. of employees |
-1
|
157
|
20 |
| Chg. No. of employees % |
0%
|
30%
|
4% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.